Alector (ALEC) Other Working Capital Changes (2018 - 2026)
Alector (ALEC) reported Other Working Capital Changes of -$1.0 million for Q1 2026, up 71.53% year-over-year from -$609807.0 in Q1 2025, and up 95.08% quarter-over-quarter from -$21.3 million in Q4 2025.
Alector (ALEC) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Other Working Capital Changes data on file, last reported at -$1.0 million in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$1.0 million, up 71.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$18.4 million (down 181.26% YoY), and the FY2025 annual result was -$21.0 million, down 632.25% from the prior year.
- Other Working Capital Changes improved to -$1.0 million in Q1 2026 per ALEC's latest filing, from -$21.3 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $93.2 million in Q2 2022 and troughed at -$95.6 million in Q3 2022.
- A 5-year average of -$1.5 million and a median of -$657000.0 in 2025 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 22614.49% in 2022 and fell as far as 3093.05% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $526000.0 in 2022, then tumbled by 314.83% to -$1.1 million in 2023, then tumbled by 142.04% to -$2.7 million in 2024, then plunged by 677.15% to -$21.3 million in 2025, then surged by 95.08% to -$1.0 million in 2026.
- Business Quant data shows ALEC's Other Working Capital Changes at -$1.0 million in Q1 2026, -$21.3 million in Q4 2025, and -$268000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.05 Mn |
| Mar 31, 2026 | -1.05 Mn |
| Dec 31, 2025 | -21.26 Mn |
| Dec 31, 2025 | -21.26 Mn |
| Sep 30, 2025 | -268,000.00 |
| Sep 30, 2025 | -268,000.00 |
| Jun 30, 2025 | 4.15 Mn |
| Jun 30, 2025 | 4.15 Mn |
| Mar 31, 2025 | -3.67 Mn |
| Mar 31, 2025 | -3.67 Mn |
| Dec 31, 2024 | -2.74 Mn |
| Dec 31, 2024 | -2.74 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Dec 31, 2023 | -1.13 Mn |
| Dec 31, 2023 | -1.13 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Sep 30, 2023 | 3.02 Mn |